These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19584039)

  • 1. Cutaneous mast cell tumour within a lipoma in a boxer.
    Jakab C; Szász AM; Kulka J; Schaff Z; Rusvai M; Németh T; Gálfi P
    Acta Vet Hung; 2009 Jun; 57(2):263-74. PubMed ID: 19584039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors.
    Joselevitch JA; Barra CN; Vargas THM; Pulz LH; Nishiya AT; Kleeb SR; Xavier JG; Catão-Dias JL; Strefezzi RF
    Vet Pathol; 2018 Nov; 55(6):849-852. PubMed ID: 30025495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
    Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
    Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.
    Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA
    Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell tumour in a young boxer dog.
    Mahler S
    Vet Rec; 2012 Aug; 171(7):182. PubMed ID: 22904029
    [No Abstract]   [Full Text] [Related]  

  • 6. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
    Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
    Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors.
    Davies DR; Wyatt KM; Jardine JE; Robertson ID; Irwin PJ
    J Am Anim Hosp Assoc; 2004; 40(2):124-30. PubMed ID: 15007048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.
    Fernandez NJ; West KH; Jackson ML; Kidney BA
    Vet Pathol; 2005 Jul; 42(4):437-45. PubMed ID: 16006603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
    Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
    BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF expression in dog mastocytoma.
    Mederle O; Mederle N; Bocan EV; Ceauşu R; Raica M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):185-8. PubMed ID: 20509299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases.
    O'Connell K; Thomson M
    Vet Comp Oncol; 2013 Mar; 11(1):51-62. PubMed ID: 22235766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs.
    Fonseca-Alves CE; Bento DD; Torres-Neto R; Werner J; Kitchell B; Laufer-Amorim R
    Res Vet Sci; 2015 Oct; 102():122-6. PubMed ID: 26412531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological grading of canine cutaneous mast cell tumours.
    Scarpa F; Sabattini S; Bettini G
    Vet Comp Oncol; 2016 Sep; 14(3):245-51. PubMed ID: 24717019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is your diagnosis? Diagnostic imaging findings and interpretation.
    Smith JR; LeBlanc AK; Hecht S
    J Am Vet Med Assoc; 2008 Aug; 233(3):385-6. PubMed ID: 18673023
    [No Abstract]   [Full Text] [Related]  

  • 15. [A mastocytoma in a dog].
    Teske E; Kirpensteijn J; Rutteman GR
    Tijdschr Diergeneeskd; 2007 Feb; 132(4):122-6. PubMed ID: 17366874
    [No Abstract]   [Full Text] [Related]  

  • 16. Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki-67 expression.
    Sakai H; Noda A; Shirai N; Iidaka T; Yanai T; Masegi T; Shirai N; Iidaka T; Yanai T; Masegi T
    J Comp Pathol; 2002 Nov; 127(4):233-8. PubMed ID: 12443730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.
    Welle MM; Bley CR; Howard J; Rüfenacht S
    Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary tumoural valvulopathy in a dog.
    Jakab C; Szász AM; Kulka J; Baska F; Rusvai M; Gálfi P; Németh T
    Acta Vet Hung; 2009 Mar; 57(1):63-7. PubMed ID: 19457774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell tumors in a llama (Lama glama).
    Lin TY; Hamberg A; Pentecost R; Wellman M; Stromberg P
    J Vet Diagn Invest; 2010 Sep; 22(5):808-11. PubMed ID: 20807950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Elders RC; Baines SJ; Catchpole B
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):11-6. PubMed ID: 19185923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.